Levetiracetam and Supraventricular extrasystoles - a phase IV clinical study of FDA data


Supraventricular extrasystoles is found among people who take Levetiracetam, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Levetiracetam and have Supraventricular extrasystoles. It is created by eHealthMe based on reports of 60,115 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

60,115 people reported to have side effects when taking Levetiracetam.
Among them, 10 people (0.02%) have Supraventricular extrasystoles.

What is Levetiracetam?

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 60,619 Levetiracetam users for its effectiveness, alternative drugs and more.

What is Supraventricular extrasystoles?

Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle) is found to be associated with 1,313 drugs and 652 conditions by eHealthMe.

Number of Levetiracetam and Supraventricular extrasystoles reports submitted per year:

Could Levetiracetam cause Supraventricular extrasystoles?

Gender of people who have Supraventricular extrasystoles when taking Levetiracetam *:

  • female: 12.5 %
  • male: 87.5 %

Age of people who have Supraventricular extrasystoles when taking Levetiracetam *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Levetiracetam *:

  1. Xanax: 5 people, 50.00%
  2. Clexane: 5 people, 50.00%
  3. Mekinist: 4 people, 40.00%
  4. Amlodipine: 4 people, 40.00%
  5. Tafinlar: 4 people, 40.00%
  6. Zantac: 2 people, 20.00%
  7. Eslicarbazepine Acetate: 2 people, 20.00%
  8. Zosyn: 1 person, 10.00%
  9. Dyazide: 1 person, 10.00%
  10. Dynacirc: 1 person, 10.00%

Common side effects people have besides Supraventricular extrasystoles *:

  1. Fatigue (feeling of tiredness): 8 people, 80.00%
  2. Cough: 7 people, 70.00%
  3. Diarrhea: 7 people, 70.00%
  4. Atrioventricular Block First Degree (heart block first degree): 7 people, 70.00%
  5. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 70.00%
  6. Arrhythmias (irregular heartbeat): 6 people, 60.00%
  7. Drowsiness: 6 people, 60.00%
  8. Nausea And Vomiting: 6 people, 60.00%
  9. Constipation: 6 people, 60.00%
  10. Anaemia (lack of blood): 6 people, 60.00%

Common conditions people have *:

  1. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 5 people, 50.00%
  2. Colon Cancer: 5 people, 50.00%
  3. Partial Seizures (seizures which affect only a part of the brain at onset): 2 people, 20.00%
  4. Neoplasm Malignant (cancer tumour): 1 person, 10.00%
  5. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 10.00%
  6. B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Levetiracetam and have Supraventricular extrasystoles?

Check whether Supraventricular extrasystoles is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Supraventricular extrasystoles and when was it recovered:

Expand to all the drugs that have ingredients of levetiracetam:

Alternative drugs to, pros and cons of Levetiracetam:

Common Levetiracetam side effects:

Browse all side effects of Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Supraventricular extrasystoles treatments and more:

COVID vaccines that are related to Supraventricular extrasystoles:

Common drugs associated with Supraventricular extrasystoles:

All the drugs that are associated with Supraventricular extrasystoles:

Common conditions associated with Supraventricular extrasystoles:

All the conditions that are associated with Supraventricular extrasystoles:

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: